Agenus and Zydus sign agreements for botensilimab and balstilimab

Agenus has signed $141m partnership agreements with Zydus Lifesciences, expanding patient access to BOT/BAL.

Jun 5, 2025 - 06:00
Agenus and Zydus sign agreements for botensilimab and balstilimab
Agenus has signed $141m partnership agreements with Zydus Lifesciences, expanding patient access to BOT/BAL.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow